Rx only · Capsule, Extended Release · Oral
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate
Brands: Mixed Salts Of A Single Entity Amphetamine Product Xr · Mixed Salts Of A Single-Entity Amphetamine Product · Amphetamine Aspartate Monohydrate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate
4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US23 NDCs
4 active makers
4 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers4 labelers
Packages23
DEA / ScheduleCII
US acquisition costNADAC · per unit
Average across 19 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$3.359
Latest avg · Jun 17, 2026
-2%
Since Dec 17, 2025
4
Active US suppliers
70%
Top-2 supplier share*
Who makes it4 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| SpecGx LLC | unknown | 10 | SUPPLYING |
| Actavis Pharma, Inc. | unknown | 6 | SUPPLYING |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | unknown | 4 | SUPPLYING |
| Catalent Pharma Solutions, LLC | unknown | 3 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.
Pill